Asberg, A. Et Al. 2007. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION , vol.7, no.9 , 2106-2113.

Asberg, A., Humar, A., Rollag, H., Jardine, A. G., Mouas, H., Pescovitz, M. D., ... Sgarabotto, D.(2007). Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION , vol.7, no.9, 2106-2113.

Asberg, A. Et Al. "Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients," AMERICAN JOURNAL OF TRANSPLANTATION , vol.7, no.9, 2106-2113, 2007

Asberg, A. Et Al. "Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients." AMERICAN JOURNAL OF TRANSPLANTATION , vol.7, no.9, pp.2106-2113, 2007

Asberg, A. Et Al. (2007) . "Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients." AMERICAN JOURNAL OF TRANSPLANTATION , vol.7, no.9, pp.2106-2113.

@article{article, author={A. Asberg Et Al. }, title={Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients}, journal={AMERICAN JOURNAL OF TRANSPLANTATION}, year=2007, pages={2106-2113} }